-S1 Methods and Results.
In order to account for the variability introduced by the resampling procedure, we created five unique bootstrapped datasets and re-ran the analyses in each of them. We also re-ran the sensitivity analyses in these bootstrapped datasets under the extreme 'worst-case' assumption, in which all unknown causes of death were classified as fatal CV events.
Overall, these results were consistent with the main findings using the BIS study population; overestimation of fatal CV event risk by the SCORE OP was observed and the SCORE showed comparatively better performance. The calibration plots (12 in total) of one resampled dataset analysis are shown in Supplemental Fig. 3 . Supplemental Tables and Figures   S1 Under this extreme 'worst case' assumption, all deaths of unknown cause were considered as being of cardiovascular nature. a SCORE OP [3] and SCORE [2] scores have been previously described elsewhere. 5y indicates 5-year risk equations. H and L indicate high-and low-cardiovascular risk regions. Unless otherwise specified, 10-year risk equations were used. b Weibull regression model projections beyond the observed follow-up are reported for 10-year risk scores, leading to small differences in the number of actual events. 5-year risk scores use observed Berlin Initiative Study data only using the Kaplan-Meier estimator. c Risk score discrimination capability was assessed using observed follow-up data only.
S2 Fig. Diagnostic plots for Weibull regression models used in projections.
We created diagnostic plots to check the distributional assumptions of the Weibull regression models used to project a) SCORE-H, b) SCORE-L, c) SCORE OP-H, and d) SCORE OP-L fatal CV event probabilities beyond the follow-up period. Plots show the logarithm of the cumulative hazard against the logarithm of the survival time for each decile group. Roughly straight and parallel lines indicate Weibull and proportional hazards assumptions hold. CHD_pred<-(sex=="F")*( 0.121*(serum_chol_mmol_on_L-6)+0.007*(SBP_mmHg-120)+0.147*(age-65)+0.629*smoking-0.559*(HDL_chol_mmol_on_L-1) +0.832*diabetes)+(sex=="M")*( 0.210*(serum_chol_mmol_on_L-6)+0.008*(SBP_mmHg-120)+0.118*(age-65)+0.584*smoking-0.411*(HDL_chol_mmol_on_L-1) +0.610*diabetes) no_CHD_pred<-(sex=="F")*( 0.007*(SBP_mmHg-120)+0.162*(age-65)+0.428*smoking-0.150*(HDL_chol_mmol_on_L-1)+0.654*diabetes)+(sex=="M")*( 0.007*(SBP_mmHg-120)+0.138*(age-65)+0.567*smoking-0.284*(HDL_chol_mmol_on_L-1)+0.475*diabetes) CHD_s0<-(years==10)*(sex=="F")*(high_risk_region==1)*0.980247+(years==10)*(sex=="F")*(high_risk_region==0)*0.990066+ (years==5)*(sex=="F")*(high_risk_region==1)*0.99342114+(years==5)*(sex=="F")*(high_risk_region==0)*0.99686523+(years= =10)*(sex=="M")*(high_risk_region==1)*0.950969+(years==10)*(sex=="M")*(high_risk_region==0)*0.977713+(years==5)*(sex= ="M")*(high_risk_region==1)*0.98487626+(years==5)*(sex=="M")*(high_risk_region==0)*0.99065776 no_CHD_s0<-(years==10)*(sex=="F")*(high_risk_region==1)*0.984806+(years==10)*(sex=="F")*(high_risk_region==0)*0.9888 39+(years==5)*(sex=="F")*(high_risk_region==1)*0.99550004+(years==5)*(sex=="F")*(high_risk_region==0)*0.9971497+(year s==10)*(sex=="M")*(high_risk_region==1)*0.98063+(years==10)*(sex=="M")*(high_risk_region==0)*0.980119+(years==5)*(sex =="M")*(high_risk_region==1)*0.99377834+(years==5)*(sex=="M")*(high_risk_region==0)*0.99379587
CHD_prob<-1-CHD_s0^exp(CHD_pred) no_CHD_prob<-1-no_CHD_s0^exp(no_CHD_pred) prob<-1-(1-CHD_prob)*(1-no_CHD_prob) return(prob) } # Simulation of calibration assessment: # Note: We have simulated data to allow readers to explore our modeling and # calibration procedures. See our data sharing statement for information on # how to access original BIS data. # (A proposal with primary investigator approval required) ## Simulated data n<-1000 shape=1.3 scale=15 dataset<-data.frame(time_event=rweibull(n,shape,scale=scale),time_censor=runif(n,min=0,max=8)) dataset$status<-ifelse(dataset$time_event<dataset$time_censor,1,0) dataset$time<-apply(dataset[,c("time_event","time_censor")],1,min) dataset$age<-rpois(n,60) dataset$sex<-sample(c("M","F"),size=n,replace=T) dataset$serum_chol_mg_on_dL<-rnorm(n,140,50) dataset$SBP_mmHg<-rnorm (n,130,20) dataset$smoking<-sample(c(0,1),size=n,replace=T) dataset$HDL_chol_mg_on_dL<-rnorm(n,45,10) dataset$diabetes<-sample(c (0,1) ## Model to estimate projected probabilities by decile group survival::survreg(out~ -1+pred_risk_cat,dist="weibull",data=dataset)->mod SurvRegCensCov::WeibullDiag(out~pred_risk_cat,data=dataset) actual<-1-exp(-(10/exp(mod$coefficients))^(1/mod$scale)) ## Calibration measures calibration<-data.frame(predicted_cat=levels(dataset$pred_risk_cat),predicted_mean,actual,numerosity,row.names=NULL) calibration$predicted_events<-calibration$predicted_mean*calibration$numerosity calibration$actual_events<-calibration$actual*calibration$numerosity calibration$Chi<-(calibration$numerosity*(calibration$actual-calibration$predicted_mean)^2)/(calibration$predicted_mean*(1-cal ibration$predicted_mean)) calibration
